HLA-identical sibling donor bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: influence of GVHD prophylaxis on outcome.
Marks, D I
HLA-identical sibling donor bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: influence of GVHD prophylaxis on outcome. [electronic resource] - British journal of haematology Jul 1992 - 383-90 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
0007-1048
10.1111/j.1365-2141.1992.tb08244.x doi
Adolescent
Adult
Bone Marrow Transplantation--immunology
Child
Cyclosporine--therapeutic use
DNA, Neoplasm--genetics
Drug Therapy, Combination
Female
Fusion Proteins, bcr-abl--genetics
Graft vs Host Disease--immunology
HLA Antigens--immunology
Histocompatibility--immunology
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--immunology
Male
Methotrexate--therapeutic use
Middle Aged
Polymerase Chain Reaction
Prognosis
RNA, Messenger--analysis
Recurrence
Transcription, Genetic--genetics
HLA-identical sibling donor bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: influence of GVHD prophylaxis on outcome. [electronic resource] - British journal of haematology Jul 1992 - 383-90 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
0007-1048
10.1111/j.1365-2141.1992.tb08244.x doi
Adolescent
Adult
Bone Marrow Transplantation--immunology
Child
Cyclosporine--therapeutic use
DNA, Neoplasm--genetics
Drug Therapy, Combination
Female
Fusion Proteins, bcr-abl--genetics
Graft vs Host Disease--immunology
HLA Antigens--immunology
Histocompatibility--immunology
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--immunology
Male
Methotrexate--therapeutic use
Middle Aged
Polymerase Chain Reaction
Prognosis
RNA, Messenger--analysis
Recurrence
Transcription, Genetic--genetics